APA

Coloma Bazán E., Donate López C., Moreno Lozano P., Cervera R. & Espinosa G. (20140124). Discontinuation of anticoagulation or antiaggregation treatment may be safe in patients with primary antiphospholipid syndrome when antiphospholipid antibodies became persistently negative. : Immunologic research.

Chicago

Coloma Bazán Emmanuel, Donate López Carolina, Moreno Lozano Pedro, Cervera Ricard and Espinosa Gerard. 20140124. Discontinuation of anticoagulation or antiaggregation treatment may be safe in patients with primary antiphospholipid syndrome when antiphospholipid antibodies became persistently negative. : Immunologic research.

Harvard

Coloma Bazán E., Donate López C., Moreno Lozano P., Cervera R. and Espinosa G. (20140124). Discontinuation of anticoagulation or antiaggregation treatment may be safe in patients with primary antiphospholipid syndrome when antiphospholipid antibodies became persistently negative. : Immunologic research.

MLA

Coloma Bazán Emmanuel, Donate López Carolina, Moreno Lozano Pedro, Cervera Ricard and Espinosa Gerard. Discontinuation of anticoagulation or antiaggregation treatment may be safe in patients with primary antiphospholipid syndrome when antiphospholipid antibodies became persistently negative. : Immunologic research. 20140124.